Journal article

Publication year: 2019

Pages: 1807-1815

Journal: Thrombosis and Haemostasis

Volume number: 119

Issue number: 11

ISSN: 0340-6245

eISSN: 2567-689X

Open access status: Green

DOI Link: https://doi.org/10.1055/s-0039-1696716

Publisher: Thieme Publishing

Abstract: 
Background Fetal/neonatal alloimmune thrombocytopenia (FNAIT) results from maternal alloantibodies (abs) reacting with fetal platelets expressing paternal human platelet antigens (HPAs), mostly HPA-1a. Anti-HPA-1a abs, are the most frequent cause of severe thrombocytopenia and intracranial hemorrhage (ICH). Objectives Titration of anti-HPA-1a in maternal serum using standard National Institute for Biological Standards and Control (NIBSC) 03/152 is one diagnostic approach to predict the severity of FNAIT. Recently, we found three anti-HPA-1a subtypes reacting with the beta 3 subunit independently or dependently from complexes with alpha IIb and alpha v. Endothelial cell-reactive anti-alpha v beta 3 abs were found predominantly in cases with ICH. Our aim was to assess whether available standard material represents all anti-HPA-1a subtypes. Materials and Methods In this study, anti-HPA-1a sera (NIBSC 03/152) and human monoclonal antibodies (moabs) against HPA-1a (moabs 26.4 and 813) were evaluated using transfected cell lines expressing alpha IIb beta 3, alpha v beta 3 or monomeric c beta 3. Results Flow cytometry analyses with well-characterized murine moabs recognizing alpha IIb beta 3, alpha v beta 3, or beta 3 alone demonstrated that AP3 reacts compound-independently, whereas compound-dependent moabs Gi5 and 23C6 reacted only with complexes. NIBSC 03/152, moabs 26.4, and 813 against HPA-1a reacted like AP3, same results were obtained with monomeric c beta 3 in immunoblotting. Antigen capture assay targeting endothelial cells showed anti-HPA-1a reactivity disappearance after c beta 3 beads adsorption. Furthermore, in contrast to anti-HPA-1a abs from ICH cases, none of NIBSC 03/152, 26.4, and 813 inhibited tube formation. Conclusion These results suggest that current anti-HPA-1a standard material contains only the anti-beta 3 subtype. The absence of anti-alpha v beta 3 makes NIBSC 03/152 less suitable as standard to predict the severity of FNAIT.

Harvard Citation style: Bayat, B., Traum, A., Berghoefer, H., Werth, S., Zhu, J., Bein, G., et al. (2019) Current Anti-HPA-1a Standard Antibodies React with the β3 Integrin Subunit but not with αIIbβ3 and αvβ3 Complexes, Thrombosis and Haemostasis, 119(11), pp. 1807-1815. https://doi.org/10.1055/s-0039-1696716

APA Citation style: Bayat, B., Traum, A., Berghoefer, H., Werth, S., Zhu, J., Bein, G., Sachs, U., & Santoso, S. (2019). Current Anti-HPA-1a Standard Antibodies React with the β3 Integrin Subunit but not with αIIbβ3 and αvβ3 Complexes. Thrombosis and Haemostasis. 119(11), 1807-1815. https://doi.org/10.1055/s-0039-1696716